{"nctId":"NCT01412372","briefTitle":"The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study","startDateStruct":{"date":"2010-06"},"conditions":["Irritable Bowel Syndrome"],"count":61,"armGroups":[{"label":"Placebo","type":"EXPERIMENTAL","interventionNames":["Drug: Placebo"]},{"label":"Mesalamine","type":"EXPERIMENTAL","interventionNames":["Drug: Mesalamine"]}],"interventions":[{"name":"Mesalamine","otherNames":["Lialda"]},{"name":"Placebo","otherNames":["Inactive drug"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nInclusion Criteria\n\n1. Men and women age 18-75 years\n2. Rome III criteria for IBS\n3. Symptom onset after apparent acute gastroenteritis\n4. Symptoms of 6 months or greater duration\n5. Normal gross appearance of the colonic mucosa other than erythema\n6. Negative markers for celiac disease and inflammatory bowel disease\n7. Normal thyroid function and serum calcium\n8. Stable medication regimens for other medical conditions.\n\nExclusion Criteria:\n\n1. Age \\<18 or \\>75 years\n2. Previous diagnosis of or history compatible with IBS\n3. Constipation-predominant IBS.\n4. Clinically significant chronic cardiac, pulmonary, hepatic, renal dysfunction or HIV\n5. History of/or presence of malignancy\n6. Current evidence of any gastrointestinal disorder such as celiac disease, inflammatory bowel disease, chronic pancreatitis, scleroderma, HIV, small bowel or colonic resection, paraplegia or quadriplegia. .\n7. Current evidence of drug or alcohol abuse as judged by the investigator\n8. Allergy to mesalamine or aspirin\n9. Investigator perception of patient's inability to comply with the study protocol\n10. Unstable psychiatric disease\n11. Recent change in gastrointestinal medications","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"75 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Average Overall Bowel Symptom Score (BSS) After an 8 Week Treatment Period","description":"BSS score measured from sum of BSS items of abdominal pain severity, bloating severity, diarrhea severity, constipation severity, and how satisfied are you with bowel habits, and measured on a scale of 0% to 100%, 0 being not severe and 100 being very severe.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4","spread":"3"},{"groupId":"OG001","value":"-13","spread":"3"}]}]}]},{"type":"SECONDARY","title":"Change in Average Overall IBS Specific Quality of Life Score After an 8 Week Treatment Period.","description":"As measured by the IBS specific Quality of Life questionnaire which consists of 34 items scored on a scale of 0% to 100%, 0 being not at all and 100 being extremely.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":"4"},{"groupId":"OG001","value":"8","spread":"4"}]}]}]},{"type":"SECONDARY","title":"Change in Average Bowel Frequency After 8-Week Treatment Period","description":"Measured by the participant reported average number of daily bowel movements.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.0","spread":"0.5"},{"groupId":"OG001","value":"-0.9","spread":"0.3"}]}]}]},{"type":"SECONDARY","title":"Change in Average Bowel Consistency Score After an 8 Week Treatment Period.","description":"Measured using the Bristol Stool form scale 1-7, with 1 being the most formed and 7 the least formed.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.5","spread":"0.2"},{"groupId":"OG001","value":"-0.8","spread":"0.3"}]}]}]},{"type":"SECONDARY","title":"Change in Average Abdominal Pain Score After an 8 Week Treatment Period","description":"Measured on a scale of 0% to 100%, 0 being not severe and 100 being very severe.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5","spread":"6"},{"groupId":"OG001","value":"-9","spread":"4"}]}]}]},{"type":"SECONDARY","title":"Change in Average Bloating Score After an 8 Week Treatment Period.","description":"Measured on a scale of 0% to 100%, 0 being not severe and 100 being very severe.","paramType":"MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-4","spread":"4"},{"groupId":"OG001","value":"-8","spread":"6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":["Sinusitis","light headed/dizziness","Abdominal Pain","Bloating","Increased bowel movement"]}}}